Dr. DeAnnuntis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
500 Arcola Road
Collegeville, PA 19426Phone+1 484-565-3332- Is this information wrong?
Education & Training
- University of California (Irvine)Residency, Internal Medicine, 1993 - 1996
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1993
Certifications & Licensure
- NJ State Medical License 1997 - 2025
- PA State Medical License 1997 - 1998
Publications & Presentations
PubMed
- 5 citationsTalazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses.Niven Mehra, Karim Fizazi, Johann S de Bono, Philippe Barthélémy, Tanya Dorff, Adam Stirling, Jean-Pascal Machiels, Davide Bimbatti, Deepak Kilari, Herlinde Dumez, Con...> ;The Oncologist. 2022 Oct 1
- 14 citationsPregnancy outcomes in patients treated with bosutinib.Jorge E. Cortes, Carlo Gambacorti-Passerini, Michael M.N. Deininger, Elisabetta Abruzzese, Liza DeAnnuntis, Tim H. Brümmendorf> ;International Journal of Hematologic Oncology. 2020 May 29
- Talazoparib in Patients with a Germline BRCA-Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial.Sara A Hurvitz, Anthony Gonçalves, Hope S Rugo, Kyung-Hun Lee, Louis Fehrenbacher, Lida A Mina, Sami Diab, Joanne L Blum, Jayeta Chakrabarti, Mohamed Elmeliegy, Liza D...> ;The Oncologist. 2020 Mar 1
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: